Option Care Health (OPCH) Tops Q3 EPS by 5c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2020
November 3, 2020 6:30 AM ESTBANNOCKBURN, Ill., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the Company or Option Care Health) (Nasdaq: OPCH), the nations largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2020.
Given the merger between HC Group Holdings II, Inc. (Option Care) and BioScrip, Inc. (BioScrip) to form Option Care Health on August 6, 2019, comparisons to historical periods are relative to legacy Option Care only and incorporate BioScrip results from August 6, 2019 prospectively. Further, as reported on February 3, 2020, the Company completed a reverse 1-for-4 stock split in the... More
